Vertex to Acquire Crinetics Pharmaceuticals for $85 a share
MLex Summary: Boston-based Vertex Pharmaceuticals agreed to acquire San Diego-based Crinetics Pharmaceuticals for $85/share giving it a total equity value of about $10 billion. Both companies are traded on the Nasdaq. The...To view the full article, register now.
Already a subscriber? Click here to view full article